Monitoring Antimicrobial Use and Resistance: Comparison with a National Benchmark on Reducing Vancomycin Use and Vancomycin-Resistant Enterococci

Fridkin, Scott K.; Lawton, Rachel; Edwards, Jonathan R.; Tenover, Fred C.; McGowan Jr., John E.; Gaynes, Robert P.
July 2002
Emerging Infectious Diseases;Jul2002, Vol. 8 Issue 7, p702
Academic Journal
Focuses on a study which analyzed data from 50 intensive-care units at 20 U.S. hospitals reporting data on antimicrobial-resistant organisms and antimicrobial agent use, to determine if local monitoring data on vancomycin use directed quality improvement and decreased vancomycin-resistant enterococci (VRE). Overview of the emerging problem of antimicrobial resistance in bacterial pathogens; Methodology; Results of the study.


Related Articles

  • Prevention of Resistance: A Goal for Dose Selection for Antimicrobial Agents. Drusano, G.L. // Clinical Infectious Diseases;1/15/2003 Supplement 1, Vol. 36, pS42 

    Drug-resistant microorganisms have become a major problem around the world. In nosocomial and community settings, many important pathogens have demonstrated high-grade resistance to many of our most important agents. In addition, the adverse impact of resistance has not been limited to the...

  • Antimicrobial resistance: Bacteria on the defence. Levy, Stuart B. // BMJ: British Medical Journal (International Edition);09/05/98, Vol. 317 Issue 7159, p612 

    Looks at antimicrobial resistance, focussing on the behavior of bacterial agents. Introduction of resistant bacteria from hospital; Results of studies of emerging resistant bacteria; Results of studies concerning resistance in bacteria.

  • Surveillance of antimicrobial resistance. Wale, Martin C.J. // BMJ: British Medical Journal (International Edition);09/05/98, Vol. 317 Issue 7159, p614 

    Looks at the surveillance of antimicrobial resistance, highlighting the gathering of data to approach the problem of antibiotic resistance. Results of centralised testing; Benefits of international cooperation on surveillance of resistance. INSET: A surveillance system for Europe.

  • Antimicrobial resistance in developing countries. Hart, C.A.; Kariuki, S. // BMJ: British Medical Journal (International Edition);09/05/98, Vol. 317 Issue 7159, p647 

    Examines the occurrence of antimicrobial resistance in developing countries. Projects of disability adjusted life; Availability of antimicrobial drugs in developing countries; Description of how antimicrobial drugs are used; Analysis of accute respiratory tract infections.

  • Surveillance of antimicrobial resisitance--an international perspective. Williams, R.J.; Ryan, M.J. // BMJ: British Medical Journal (International Edition);09/05/98, Vol. 317 Issue 7159, p651 

    Discusses the importance of surveillance for containing antimicrobial resistance. Problem of antimicrobial resistance worldwide; Requirements of the surveillance for controlling antimicrobial resistance. INSET: Summary points.

  • Derriere to the Future: Is It Time to Rethink How We Use Antimicrobial Agents? Tillotson, Glenn S. // Clinical Infectious Diseases;4/15/2001, Vol. 32 Issue 8, p1189 

    Addresses problems associated with the emergence of bacterial resistance to antimicrobial agents. Role of frequent low-level use of antibiotics in bacterial resistance; Application of Ehrlich's statement to the use of antibiotics.

  • The microbial threat: Copenhagen recommendations.  // WHO Drug Information;1999, Vol. 13 Issue 1, p12 

    Reports on the recommendations of Ministers of Health from European Union countries during a meeting in Copenhagen, Denmark on the increasing resistance of microorganisms to anti-microbial agents. Need for rational use of anti-microbial agents; Development of new drugs; Surveillance system of...

  • A novel antimicrobial agent joins the battle against resistant bacteria. Moellering Jr., Robert C. // Annals of Internal Medicine;01/19/99, Vol. 130 Issue 2, p155 

    Editorial. Cites the potential of Linezolid as a novel antimicrobial agent that can address the problem of bacterial resistance. Advent of resistant gram-positive bacteria; Chemical modification of known agent; Linezolid's superior pharmacokinetic properties; Bacteriostatic against...

  • Common bacterial pathogens and resistance to antibiotics. Sanderson, P.J. // British Medical Journal (Clinical Research Edition);9/15/1984, Vol. 289 Issue 6446, p638 

    Examines the resistance of common bacterial pathogens to antibiotics in North America. Importance of clinical strategies to combat antibiotic resistance; Aims of antimicrobial treatment; Prevention of cross infection.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics